EPAC vs RDW

EPAC presents a stark contrast between a healthy balance sheet and a severely overvalued market price. While the Piotroski F-Score of 4/9 indicates stable financial health and the company maintains strong margins and low debt, the stock is trading at a massive premium to its Graham Number ($16.82) and Intrinsic Value ($11.13). This valuation gap is exacerbated by negative earnings growth (-18.4% YoY) and a completely bearish technical trend (0/100). Despite strong ROE, the lack of earnings momentum and the significant distance from defensive fair value suggest limited upside and high downside risk.

RDW presents a profile of high-growth instability, characterized by a stable Piotroski F-Score of 5/9 but a complete lack of profitability. While revenue growth is impressive at 56.4%, the company has missed earnings estimates in 4 of the last 4 quarters with a severe average surprise of -308.16%. The balance sheet is a primary strength with very low debt (D/E 0.11) and healthy liquidity, yet significant insider selling ($46.44M) suggests a lack of confidence at current levels. Overall, the stock is a speculative growth play where fundamental losses clash with strong top-line expansion.